Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
Aquestive Therapeutics Inc (NQ: AQST)
5.690   UNCHANGED
Streaming Delayed Price  /  Updated: 7:39 PM EDT, Aug 3, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 5.690
Bid (Size) 4.020 (1)
Ask (Size) 5.690 (1)
Prev. Close 5.690
Today's Range 5.690 - 5.690
52wk Range 1.410 - 10.00
Shares Outstanding N/A
Dividend Yield N/A
Performance
YTD
-5.64%
-5.64%
1 Month
+20.55%
+20.55%
3 Month
+26.44%
+26.44%
6 Month
+44.05%
+44.05%
1 Year
+81.79%
+81.79%
Top News
More News
Aquestive Therapeutics to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
from GlobeNewswire News Releases
Aquestive Therapeutics to Announce Second Quarter Financial Results and Recent Business Highlights on Aug 4 and Host Conference Call on Aug 5 at 8:00 a.m. ET
from GlobeNewswire News Releases
More News
Read More
Aquestive Therapeutics Files IND for Pharmacokinetic Clinical Trials of AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) for Anaphylaxis Treatment
from GlobeNewswire News Releases
Aquestive Therapeutics to Present at BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference
from GlobeNewswire News Releases
Aquestive Therapeutics to Hold Virtual-Only Annual Meeting of Stockholders
from GlobeNewswire News Releases
Aquestive Therapeutics Advances Royalty Monetization Plan as Sunovion Pharmaceuticals’ Apomorphine Sublingual Film Therapy Receives FDA Approval
from GlobeNewswire News Releases
Aquestive Therapeutics to Present at 2020 RBC Capital Markets Global Healthcare Conference
from GlobeNewswire News Releases
Aquestive Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Update: AQST-108 and Libervant Remain On Track
from GlobeNewswire News Releases
Thinking about buying stock in Xeris Pharmaceuticals, Aquestive Therapeutics, Navidea Biopharmaceuticals, Sundial Growers, or Hexo Corp?
from PR Newswire
UPDATE 1-U.S. FDA approves Parkinson's treatment from Sunovion Pharma
category companyNews
from Reuters: Company News
US Stock Market Weekly Update May 25- May 29, 2020
category Stocks / Equities , Healthcare , Financial , and 1 more.
from Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.